Exploratory experiment designed to discover new patterns targeting CAPZA1, YAP1 in MCF-7 and MDA-MB-231 human breast cancer cell lines. Primary outcome: Direct drug-protein interaction and F-actin disassembly
This experiment focused on identifying the direct molecular target of silibinin that mediates F-actin disassembly. The researchers used biochemical approaches to investigate the interaction between silibinin and F-actin regulatory proteins. They discovered that silibinin directly targets Capza1 (capping actin protein of muscle Z-line subunit alpha 1), which is responsible for F-actin disassembly. The study likely employed techniques such as CETSA (cellular thermal shift assay) and DARTS (drug affinity responsive target stability) to demonstrate direct drug-protein interactions. The researchers showed that Capza1-mediated F-actin disassembly is the decisive mechanism for silibinin-induced cell cycle arrest, even when YAP activity is modulated. This experiment revealed a positive feedback loop between YAP and F-actin, where promoting F-actin assembly through si-Capza1 transfection can restore YAP activity.
CETSA, DARTS, protein-drug interaction assays, siRNA transfection, F-actin visualization, YAP activity assessment
Expected to identify direct molecular target of silibinin; found Capza1 as the primary target mediating F-actin disassembly
Demonstration of direct silibinin-Capza1 interaction and rescue of phenotype by Capza1 knockdown
No related hypotheses
No debates yet
No results recorded yet. Use POST /api/experiments/{id}/results to record a result.